Volpara Health
Prevent advanced-stage cancer. Volpara's groundbreaking Breast Health Software leverages AI for clinical decision support, personalized care and quality management to ignite a revolution in early detection of breast cancer.
Breast Health Software – Volpara Health
“ Volpara Software is second to none and world leading. Volpara is solving a real-world problem and it is impacting patient care. ” – Dr Lloyd McCann, CEO, Mercy Radiology
About us – Volpara Health
Volpara Health makes software to save families from cancer. Healthcare providers use Volpara to better understand cancer risk, empower patients in personal care decisions, and guide recommendations about additional imaging, genetic testing, and other interventions.
Science – Volpara Health
Clinically validated by researchers. Trusted by breast imaging centers. Volpara’s algorithms are built on proven science. Volpara® Science™ has analyzed over 100 million mammography images and has assessed the breast composition of …
Scorecard – Volpara Health
Volpara Scorecard™ gives your breast care team the insights they need to find cancer earlier. Improve clinical decision-making with key breast density and risk insights in one view. Request a demo
Analytics – Volpara Health
Volpara Enterprise is now Volpara Analytics. Mammography analytics software powered by AI to optimize breast cancer screening operations.
Volpara AI software highlighted in new peer-reviewed research
Dec 20, 2023 · By empowering clinicians with innovative tools, Volpara exemplifies its commitment to advancing mammography quality and the early detection of breast cancer,” said Melissa Hill, Volpara Health Senior Imaging Scientist and Global Research Lead.
Lunit Completes Acquisition of Volpara: Pioneering Next-Level of …
May 22, 2024 · The acquisition of Volpara significantly boosts Lunit’s capabilities in AI-driven cancer diagnostics. With this acquisition, Lunit integrates Volpara’s advanced breast health platform—such as breast density assessment, Scorecard™, and screening workflow enhancement—with its AI-powered solutions for breast cancer detection.
Volpara Health Announces Leadership Transition, BOADICEA …
Mar 7, 2025 · Craig Hadfield, Volpara’s Chief Customer and Financial Officer, will become CEO on April 1, succeeding Teri Thomas as she pursues her next career steps. Volpara density is now a validated input to the BOADICEA breast cancer risk model.
Volpara – Volpara Health
Risk Pathways A full program for identifying, tracking, and managing high-risk patients.